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http://www.biomedcentral.com/1471-2407/14/273RESEARCH ARTICLE Open AccessInhibition of autophagy enhances the cytotoxic
effect of PA-MSHA in breast cancer
Wen-Huan Xu1,2,3,4†, Zhe-Bin Liu1,2,3†, Yi-Feng Hou1,2,3, Qi Hong1,2,3, Da-Li Hu5 and Zhi-Ming Shao1,2,3*Abstract
Background: PA-MSHA, a genetically engineered Pseudomonas aeruginosa (PA) strain, is currently under investigation
as a new anti-cancer drug. It can induce cell cycle arrest and apoptosis in different human cancer cells, including hormone
receptor negative breast cancer cells. However, the underlying mechanism of tumor lethality mediated by PA-MSHA
remains to be fully investigated.
Methods: The effect of PA-MSHA on human hormone receptor negative breast cancer cells was analyzed by
morphological measurement, western blot, cell proliferation assay and mouse xenograft model.
Results: PA-MSHA was found to induce endoplasmic reticulum (ER) stress in breast cancer cell lines through the
IRE1 signaling pathway. Inhibiting autophagy potentiated the cytotoxic effect of PA-MSHA while treating breast
cancer cell lines. In mouse xenograft model, PA-MSHA produced more pronounced tumor suppression in mice
inoculated with IRE1 gene knockdown. MDA-MB-231HM cells.
Conclusions: These findings demonstrated inhibiting autophagy together with PA-MSHA might be a promising
therapeutic strategy in treating hormone receptor negative breast cancer cells.
Keywords: PA-MSHA, ER stress, Autophagy, IRE1, Breast cancerBackground
Breast cancer, one of the leading causes of cancer related
mortality in women, is a disease with heterogeneous
nature. Meanwhile “basal-like” breast cancer, ER and PR
negative, is characterized by its aggressive behavior, dis-
tinct patterns of metastasis and lack of targeted therapies
[1,2]. PA-MSHA, a genetically engineered Pseudomonas
aeruginosa strain, has been successfully used as a pro-
tective vaccine [3] for adjuvant therapy of lymphoma
and lung cancer. In recent preclinical studies, cytotoxic
effect of PA-MSHA was observed in ER, PR negative
breast cancer cells but not in ER, PR positive breast can-
cer cells [4]. The same effect was also exhibited in hu-
man hepatocarcinoma cells treated by PA-MSHA [5].
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reproduction in any medium, provided the orcancer patients, further laboratory investigation are
needed to better understand its anticancer mechanism.
Many chemotherapeutic drugs induce cell death via
the endoplasmic reticulum (ER) stress mediated apop-
totic pathway [6,7]. ER is composed of membranous tu-
bules and vesicles. It serves cells with a Ca2+ reservoir
and facilitates the secretion of properly folded proteins
[8,9]. Disturbances in normal ER process lead to accu-
mulation of unfolded proteins and trigger the unfolded
protein response (UPR), which compensate the damage
by reducing global protein synthesis and elicit autoph-
agy, an alternate degradation system [10-12]. IRE1 and
PERK/eIF2α are reported to be involved in the induction
of autophagy upon ER stress.Autophagy can prevent the
accumulation of toxic components in cells by sequester-
ing cytoplasmic materials to autophagic vesicles and de-
grading them in the lysosome and recycling these
materials [13]. In many studies, autophagy was induced
while cancer cells faced with therapeutic stress, such as
chemotherapy, radiotherapy and endocrine therapy [14].
In present study, we found that autophagy was stimu-
lated in breast cancer cells upon ER stress of PA-MSHAThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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moted apoptosis both in vivo and in vitro. Our results
provide molecular evidence that inhibiting autophagy
will enhance PA-MSHA induced apoptosis in HR nega-
tive breast cancers.Methods
Cell lines and materials
Human breast cancer cell lines MDA-MB-231 and MDA-
MB-468 were obtained from the American Type Culture
Collection. MDA-MB-231HM cell line was established by
subclone selection procedure in our institute. The MDA-
MB-231HM cell line has a high potential to metastasize to
the lung and its establishment has been described previ-
ously [15]. The PA-MSHA used in this study was same as
we used in our previous study [4]. Following reagents and
primary antibodies were used: anti-LC3 (Cell Signaling
Technology, Danvers, MA), anti-GAPDH, anti-caspase3,
anti-cleaved-caspase3, anti-CHOP, anti-IRE1-a, anti-ATG5
(Santa Cruz Biotechnology Inc., Santa Cruz, CA); 3-MA
and tunicamycin (Sigma-Aldrich, St. Louis, MO, USA).
Lipofectamine 2000 reagent was obtained from Invitrogen
(Cat. No 11668-019).Western blot
Cell lysates were prepared by extracting proteins with
lysis buffer. Proteins were separated by sodium dodecyl
sulfate polyacrylamidel gel electrophoresis and transferred
to PVDF membranes. The membranes were blocked and
incubated with primary antibodies. After incubation with
peroxidase-conjugated secondary antibodies, the blots were
visualized by enhancing chemiluminescence reagents.Transmission electron microscopy
Transmission electron microscopy was used to determine
the effect of PA-MSHA treatment on the ultrastructure
of breast cancer cells as described by Watkins and Cullen
[16]. Ultra thin sections (65 nm) were examined under a
JEM-100CX transmission electron microscope (JEOL,
Japan) at × 84,00 or × 15,000 magnification.Flow cytometry with annexin V-FITC and PI staining
Cells were pretreated with solution containing of 2 mM 3-
MA, 10 × 108 cells/ml PA-MSHA, or 3-MA in combination
with PA-MSHA for 48 hours. Single-cell suspensions with
at least 1 × 106 cells/ml were made. Apoptotic analyses
were done by flow cytometry (FCM) as previously de-
scribed [17] using a FACScalibur system (Becton Dickinson
Biosciences, San Diego, CA). Propidium iodide-negative
and annexin V-positive cells were analyzed by quadrant sta-
tistics as apoptotic cells.Cell proliferation
Cytotoxic effect was evaluated by the Cell Counting Kit-8
(CCK-8; Dojindo Molecular Technologies Inc., Gaitherbury,
MD) assay. Cells were treated with specified concen-
tration of PA-MSHA, 3-MA or 3-MA in combination
with PA-MSHA and incubated at 37°C for 12, 24, 36 and
48 hours. Then, 10 μl of CCK-8 was added to every well,
and the cells were incubated for an additional 3 hours at
37°C, after which the absorbance at 450 nm was recorded
using a 96-well plate reader (Sunrise Microplate Reader,
Tecan US, Inc., Charlotte, NC).
Lentiviral-mediated knockdown of IRE1
Short hairpin RNA molecules targeted against human IRE1
gene were designed and synthesized by Sangon Biotech.,
Shanghai, China. The sequences of shRNAs targeting IRE1
was 5’-CTACTGGATAAACTTGCTTCA-3’. Oligonucleo-
tides were annealed and inserted into digested PLKO.1-
puro. Production of the lentiviral particles were carried
out according to the manufacturer’s protocol. MDA-MB-
231HM and MDA-MB-231HM cells were infected with
lentivirus particles containing the shRNA and stable trans-
fectants were selected and cultured in medium containing
3 ng/μl puromycin. The PLKO.1 scramble plasmid was
packaged as a negative control. The PLKO.1 puro plasmid,
packaging plasmid, pCMV- dR8.91 and envelope VSV-G
were purchased from Addgen (Cambridge, MA).
Morphological measurement of apoptosis
The morphological changes of apoptosis were assayed
under a fluorescence microscope following staining with
Hoechst 33258. Cells were treated with specified concen-
tration of PA-MSHA for 48 h at 37°C, and then stained
with 5 mg/L Hoechst 33258 (Sigma, St. Louis, MO) for
30 min at 37°C, visualized under a fluorescence micro-
scope with standard excitation filters. The apoptotic cells
were visualized at × 400 magnification.
Animal xenograft model
This study followed the ethical approval of Fudan Uni-
versity Experimental Animal Department for research
involving animals. 4-6 weeks old female BALB/c nude
mice used in the study were provided by Shanghai Institute
of Material Medica, Chinese Academy of Science. 2 × 106
cells/ml MDA-MB-231HM-shCON cells and MDA-MB-
231HM-shIRE1 cells suspended in 0.1 ml PBS were im-
planted into the mammary fat pad of mice. A total of 24
mice were randomized and assigned into four groups in the
study. These mice were given 0.1 ml PA-MSHA (2.2 × 1010
cells/ml) s.c treatment every other day. Tumor volume
was measured twice per week with calipers and calcu-
lated using the formula V (mm3) = 0.52 × ab2 (a = length,
b = width). Body weight was recorded twice a week. The
mice were killed and autopsied 6 weeks after tumor
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molecular biology analyses.
Statistical analysis
Statistical analysis was performed using the software of
Statistical Package for the Social Sciences (SPSS) Version
15 for Windows (SPSS Inc., Chicago, IL). Student’s t tests
were used to determine statistical significance of differences
between experimental groups. A P-value of less than 0.05
was considered significant. Graphs were created with Excel
software (Microsoft Office for Windows 2003).
Results
PA-MSHA induces ER stress in breast cancer cells
Compared with cells treated with PBS, increased cellular
vacuolization was observed in MDA-MB-231HM cells
treated with PA-MSHA (10 × 108 cells/ml) for 48 hours
using light microscopy (Figure 1A). Further investigation
with transmission electron microscopy identified dilated
cytoplasmic vacuoles, which were previously described as
indication of enhanced ER stress level [11], in these cells
(Figure 1B). To verify the possibility that PA-MSHA might
induce ER stress in breast cancer cells, we analyzed the
expression levels of UPR targets GRP78/Bip and CHOP.
Tunicamycin, a conventional ER stress agent, was used
as a positive control. After 48 hours’ incubation with
tunicamycin, elevated expression of GRP78/Bip as well
as CHOP were detected in MDA-MB-231HM cells.
Meanwhile significantly increased GRP78/Bip and CHOP
were also found in cells incubated with PA-MSHA, as
early as one hour after the treatment (Figure 1C). All
these indicated that PA-MSHA can induce ER stress in
MDA-MB-231HM cells.
Autophagosome formation is activated upon PA-MSHA
induced ER stress
With electron microscopy, we noticed the co-existence of
double-membrane vacuolar structures and dilated ER lu-
mens in PA-MASH-treated breast cancer cells (Figure 2A).
The double-membrane vacuolar structure was previously
described as morphological feature of autophagosome. To
testify the possibility that PA-MSHA can induce autophagy
in breast cancer cells, 3MA, a conventional autophagy
agent, was used as a positive control. The ratio of LC3-II/
LC3-I and the expression of Atg5 increased as the dose of
PA-MSHA rose. In cells treated with PA-MSHA as well as
3-MA, decreased ratio of LC3-II/LC3-I and expression of
Atg5 was found (Figure 2B, C).
Characteristic punctate fluorescent patterns of EGFP-
LC3 in cells treated with PA-MSHA for 24 hours were
also observed, indicating the existence of autophagosome
[18] (Figure 2D). Morphometric analysis of the EGFP
fluorescence images revealed that the percentage of
EGFP-LC3-punctate staining cells was 0.67% and 3.33%of the total cells in the absence and presence of PA-
MSHA respectively. The EGFP fluorescence area in-
creased about 4.97-fold after the treatment of PA-MSHA
(Figure 2E). These indicated autophagy was activated by
PA-MSHA.
The IRE1 signaling pathway is required for activation of
PA-MSHA-induced autophagy in breast cancer cells
ER stress was reported to trigger autophagy while facing
cell damage stress in many studies [10-12]. IRE1 was in-
volved in the induction of autophagy upon ER stress.
Previously, we found elevated expression of CHOP in
PA-MSHA treated breast cancer cells. Since CHOP was
also reported to be up-regulated by IRE1, we postulated
that IRE1 signaling pathway might be required for acti-
vation of PA-MSHA-induced autophagy in breast cancer
cells. IRE1-shRNA was used to confirm our hypothesis.
While treated with PA-MSHA, the LC3-II accumulation
was decreased in cells transfected with shIRE1 compared
with those transfected with shCON (Figure 3A, B). We
also observed morphological changes in cell nuclei using
Hoechst-33258. As shown in Figure 3C, dense and thin
crowns of nuclear coloration, typical of chromatin con-
densation, were observed in MDA-MB-231HM-shIRE1
cells, and less typical morphological changes were ob-
served in MDA-MB-231HM cells. Same changes were ob-
served in MDA-MB-231-shIRE1 cells. Besides, using flow
cytometric analysis, we found apoptosis induced by PA-
MSHA was augmented in cells transfected with shIRE1
compared with those transfected with shCON (Figure 3D).
All these results indicated that IRE1 pathway was required
for activation of PA-MSHA-induced autophagy in breast
cancer cells.
Protective effects of autophagy during PA-MSHA-induced
ER stress
Using light microscopy, we found cellular vacuolization
and death in MDA-MB-231 cells treated with PA-MSHA.
Increased cellular vacuolization and death was observed in
MDA-MB-231 cells treated with PA-MSHA and autophagy
inhibitor 3-MA [19]. Similar results were found in MDA-
MB-231HM and MDA-MB-468 cells (Figure 4A). This
phenomenon was confirmed by flow cytometric analysis.
Compared with groups treated by PBS, 3-MA (2 mM) or
PA-MSHA, more apoptotic cells were found in the group
treated by 3-MA (2 mM) and PA-MSHA (Figure 4B). By
cell viability test, we also detected more apoptosis in the
group treated by PA-MSHA and 3MA (Figure 4C). These
findings were consistent with results indicated in Figure 4D
and E. Compared with cells treated by PA-MSHA and
3MA, the ratio of LC3-II to LC3-I increased in cells treated
by PA-MSHA. Meanwhile apoptosis-associated caspase3
activity was activated in MDA-MB-231 cells treated with
PA-MSHA in combination with 3-MA, indicating that
Figure 1 ER stress induced by PA-MSHA in breast cancer cell lines. A. MDA-MB-231HM cells treated by PBS or PA-MSHA (10 × 108/ml) for
48 h were visualized by light microscopy. Increased cellular vacuolization was observed in PA-MSHA group. B. MDA-MB-231HM cells treated by
PBS or PA-MSHA (10 × 108/ml) for 48 h were visualized by electron microscopy (×8400). Cytoplasmic vacuoles were observed in PA-MSHA group
(Figure1B).→ point to normal ER. * indicate dilated ER cavity. N, Nucleus. C. The expression of GRP78/Bip and CHOP in MDA-MB-231HM cells
exposed to PA-MSHA (10 × 108/ml) at indicated time points. TM group: MDA-MB-231HM cells were treated by tunicamycin (5 mg/mL) for 24 hours.
CON group: MDA-MB-231HM cells were treated by PBS for 24 hours.
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to the cytotoxic (apoptotic) actions and PA-MSHA-
induced autophagy might be a cyto-protective mechanism
in hormone negative breast cancer cells.
Tumor suppression induced by PA-MSHA is enhanced by
inhibiting autophagy
Previous study showed that inhibiting autophagy in vitro
would result in more death in breast cancer cells treatedwith PA-MSHA. We next assessed whether suppression
of autophagy would also potentiate the cytotoxic effects
of PA-MSHA in vivo. We divided nude mice in four
groups: (a) mice implanted with MDA-MB-231HM-
shCON cells treated with vehicle only, (b) mice im-
planted with MDA-MB-231HM-shCON cells treated
with PA-MSHA only, (c) mice implanted with MDA-
MB-231HM-shIRE1 cells treated with vehicle only, (d)











Figure 2 Autophagy induced by PA-MSHA in breast cancer cell lines. A. MDA-MB-231HM cells treated by PA-MSHA (10 × 108/ml) for 48 h
were visualized by electron microscopy (×8400).→ point to autophagosome. * indicate dilated ER cavity. B. The expression of LC3 and ATG5 in
MDA-MB-231HM cells treated by different dosage of PA-MSHA (0, 2.5, 5, 10 × 108/ml). Con group: cells were treated by PA-MSHA (10 × 108/ml) +
PBS. 3MA group: cells were treated by PA-MSHA (10 × 108/ml) + 3-MA (2 mM). C. The relative expression of LC3-II/LC3-I and ATG5 in MDA-MB-
231HM cells treated by different dosage of PA-MSHA (2.5, 5, 10 × 108/ml) to PA-MSHA (0 × 108/ml) group and Con group. The values were the
means +/- standard deviations of three independent experiments. * indicates a significant difference compared with PA-MSHA (0 × 108/ml) group
(*, P <0.05) . ** indicates a significant difference compared with Con group (**, P < 0.05). D. Punctate fluorescent patterns of EGFP-LC3 observed
by fluorescence microscope in MDA-MB-231HM cells treated with PA-MSHA (10 × 108/ml) for 24 hours. E. The percentage of EGFP-LC3 dots positive cells
to the overall MDA-MB-231HM cells. Cells were treated with PA-MSHA (10 × 108/ml) for 24 hours. The values were the means +/- standard deviations of
three independent experiments. Asterisks indicate a significant difference from control cells (*, P <0.05) .
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5 out of 6 mice (83.3%) in the shIRE1 + PA-MSHA
group were found with tumors. Rates of grafted tumor
in the other 3 groups were 100%. One nude mouse in
shCON + PBS group died the day before all the mice
were killed.
As shown in Figure 5A, knocking down of IRE1 in
MDA-MB-231HM cells did not reduce the growth rate
of tumor xenografts (P = 0.806). PA-MSHA treatment
led to significant tumor suppression in mice (P = 0.025).Furthermore, with the help of knocking down IRE1,
PA-MSHA produced a greater decrease in tumor volume
(P = 0.035). Meanwhile, treatment of PA-MSHA caused no
significant loss in body weight in either MDA-MB-231HM-
shCON or MDA-MB-231HM-shIRE1 inoculated mice
(Figure 5B). More TUNEL-positive cells were found in
tumors treated with PA-MSHA compared with tumors
not treated with PA-MSHA. Largest number of TUNEL-
positive cells were observed in PA-MSHA+ shIRE1 com-





Figure 3 Autophagy in breast cancer cells treated by PA-MSHA was induced by ER stress via IRE1 pathway. A & B. The expression of LC3
and IRE1-a in MDA-MB-231-shIRE1, MDA-MB-231HM-shIRE1 or cells transfected with shCON vectors treated by PA-MSHA (10 × 108 cells/ml)/PBS
for 48 hours (A). The relative expression of LC3-I/LC3-II and IRE1-a of each sample (B). C. Nuclear staining of MDA-MB-231-shIRE1, MDA-MB-
231HM-shIRE1 cells and cells transfected with shCON vectors with Hoechst 33258 (original magnification, ×400). Cells were treated with PA-MSHA
(10 × 108cells/ml) or PBS for 24 hours before examination. D. The percentage of apoptotic cells in MDA-MB-231-shIRE1, MDA-MB-231HM-shIRE1
cells was measured by flow cytometric analysis with Annexin V-FITC/PI staining. Cells were transfected with shCON vectors or shIRE1 vectors.
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tion of LC3-II/LC3-I was found in 231-HM-shIRE1 cells
compared with 231-HM-shCON cells (Figure 5D, E).
Discussion
PA-MSHA , successfully used as a vaccine [20], has re-
cently been validated to induce cytotoxic effect against
human carcinoma cells [5]. PA-MSHA can also inhibit
the hormone receptor negative breast cancer cells in a
mannose-sensitive manner [4]. However, the direct mech-
anism for tumor lethality mediated by PA-MSHA remains
to be fully characterized.
In this study, we mainly focused on the tumor cyto-
toxic ability of PA-MSHA on the HR negative breast
cancer cells. We found enlarged vacuoles in HR nega-
tive breast cancers upon treatment of PA-MSHA. One
possible explanation for these vacuoles is the induction
of the UPR. UPR is an adaptive process, it can block
protein translation and allows cells to compensate for
protein accumulation and misfolding in the ER. Elevated
GRP78/Bip and CHOP expression, typical evidence of the
activation of ER stress-dependent UPR signaling pathway,
was also found in HR negative breast cancer cells treated
with PA-MSHA.However, if the damage is too severe and persistent,
ER stress will trigger autophagy to avoid cell damage,
which may include IRE1/CHOP or PERK/eIF2α path-
way. In our study, elevated CHOP and autophagy fol-
lowing PA-MSHA treatment were observed. Knocking
down of IRE1 decreased autophagy and enhanced cell
death in cells upon PA-MSHA treatment. These results
indicated autophagy, induced by IRE1, was a protective
agent of ER stress.
In our study, more TUNEL-positive cells was found
in PA-MSHA treated MDA-MB-231HM- shIRE1 cells
inoculated tumors compared with MDA-MB-231HM-
shCON cells inoculated tumors. Furthermore, increased
apoptosis was observed after autophagy was compromised
in vivo. This was consistent with previous reported studies.
One study had demonstrated that autophagy induced by
Epirubicin protected breast cancer cells [21]. Another study
revealed that autophagy acted as a survival signal in CML
cells treated with tyrosine kinase inhibitors (TKIs) and
CML cells resistant to TKIs can be abrogated by autophagy
inhibitors [22]. Endostatin was also reported to induce au-
tophagy in addition to apoptosis in endothelial cells [23].
Since inhibiting autophagy can lead to cell death [24,25],
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Figure 4 Protective effects of autophagy. A. Cells treated by 3-MA (2 mM), PA-MSHA (10 × 108/ml) or PA-MSHA together with 3-MA for 48 hours
were visualized by light microscopy. Most cellular vacuolization and death were found in cells treated with PA-MSHA and 3-MA. B. The percentage of
apoptotic cells in MDA-MB-231-shIRE1, MDA-MB-231HM-shIRE1 cells, MDA-MB-468 cells was measured by flow cytometric analysis. Cells were treated
by 3-MA (2 mM), PA-MSHA (10 × 108/ml) or PA-MSHA together with 3-MA for 48 hours (*P < 0.05). C. The viability of cells treated by PA-MSHA (10 × 108
cells/ml), 3-MA (2 mM) or PA-MSHA together with 3-MA was evaluated by Cell Counting Kit-8 assay. D & E The expression of caspase3, cleaved-caspase3
and LC3 in cells treated with PA-MSHA (10 × 108 cells/ml), PBS, 3-MA (2 mM) or PA-MSHA together with 3-MA (D). The relative expression of
cleaved-caspase3 and LC3-II/LC3-I of each sample.




















Figure 5 Protective effect of PA-MSHA on tumor growth in vivo. A. Tumor volume measured at the indicated time after MDA-MB-231HM -shIRE1,
MDA-MB-231HM-shCON cells were implanted into the mammary fat pad of mice. *P < 0.01 B. Body weight of mice measured at the indicated time
after MDA-MB- 231HM-shIRE1, MDA-MB-231HM-shCON cells were implanted into the mammary fat pad of mice. C. Apoptosis was measured by TUNEL
staining of tumor tissue sections. Tissues were counterstained with DAPI to detect cell nuclei. D & E. The expression of IRE1-a, cleaved-caspase 3, LC3
in PA-MSHA-treated xenografts (D). The relative expression of IRE1-a, cleaved-caspase3 and LC3-II/LC3-I of each sample.
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might be useful alliance of PA-MSHA in future clinical
trials. In our study, no significant body weight loss was
found in shIRE1 inoculated mice. This indicated there
might be no additional toxicity using shRNAs as au-
tophagy inhibitors. It will also be interesting to investi-
gate whether other known or novel pharmacological
inhibitors of autophagy can enhance the anticancer ac-
tivity of PA-MSHA. Chloroquine, which has been usedsafely for decades in patients which malaria prophy-
laxis, may be a good choice.
Conclusions
To our knowledge, this is the first report showing that PA-
MSHA can induce ER stress in hormone receptor negative
breast cancer cell lines. The ER stress activated autophagy
through IRE1 dependent pathway. Acting as a pro-survival
mechanism, autophagy alleviated PA-MSHA induced ER
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acquired resistance. Our data suggested that blocking
autophagy with either genetic or chemical inhibitors
may enhance the cytotoxicity induced by PA-MSHA.
The alliance of autophagy inhibitors and PA-MSHA
might be considered in future clinical trials treating
hormone receptor negative breast cancer patients.
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